Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Parexel International Corp.
Headquarters: Waltham, MA, United States of America
Website: http://www.parexel.com
Year Founded: 1983
Status: Private
BioCentury | Dec 20, 2024
Management Tracks
New business, medical and technology heads at Neutrolis
Plus: Noema hires Volker Knappertz as EVP of R&D, and updates from Lux, COA, Imbed and March Bio
BioCentury | Oct 29, 2024
Management Tracks
Biogen names new CFO, CMO
Plus management updates at Ottimo, Genascence, Pll, Nabsys 2.0 and Arbutus
BioCentury | Oct 23, 2024
Management Tracks
Shaun Grady to chair AstraZeneca UK
Plus: Phil L’Huillier named CEO of Scancell, and updates from BioPorto and Parexel
BioCentury | Sep 26, 2024
Product Development
ESMO recap: Keeping TIGIT alive, Rybrevant & immunotherapy anniversary — a BioCentury podcast
Plus: Special guest Gwyn Bebb of Parexel on his conference takeaways, COVID vaccines for cancer and radiopharma
BioCentury | Jun 12, 2024
Management Tracks
Former Fusion CFO Crowley joins Centessa
Weinhoff becomes CBO. Plus: QurAlis pads C-suite and updates from PepGen, C4 and more
BioCentury | Mar 19, 2024
Management Tracks
Syndax names new commercial head
Plus: Everest hires Sandra Zeng as CMO and Rico Liang as chief product officer, and updates from Parexel, Dignify and GRO
BioCentury | Sep 20, 2023
Management Tracks
Orwin succeeds Topper as AnaptysBio’s chair
Plus: CDMOs Catalent and Rentschler announce executive changes, and updates from Parexel, Santander, CorriXR and more
BioCentury | Apr 14, 2023
Management Tracks
Editas names Reeve chair, adds Levy to board
Plus: Exelixis proposes new directors amid ongoing tussle with activist investor and updates from Jasper, CIRM, Visus, Curemark and more
BioCentury | Aug 18, 2021
Management Tracks
Smith named CEO at Remix
Plus: Jubilant, Sparrow, n-Lorem, OncXerna and more
BioCentury | Jul 3, 2021
Deals
July 2 Quick Takes: PE firms swap Parexel in $8.5B takeout; plus Arrowhead, Cerevel, Iterum, Caribou, Beneluxa Initiative
EQT Private Equity and Goldman Sachs Asset Management’s PE unit acquired CRO Parexel International Corp. from Pamplona Capital Management. In another reminder that safety risks take time to
Items per page:
1 - 10 of 90